Clinical Trial Update: Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Vedolizumab in Crohn's disease patients naive to anti-TNF therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Universita degli Studi di Genova | Conditions: Crohn Disease | Phase 4 | Status: WITHDRAWN